Next Article in Journal
Dietary Fibers and Cardiometabolic Diseases
Previous Article in Journal
Molecular Diagnostic and Pathogenesis of Hereditary Hemochromatosis
Article Menu

Export Article

Open AccessArticle
Int. J. Mol. Sci. 2012, 13(2), 1512-1523; doi:10.3390/ijms13021512

Olmesartan Attenuates the Impairment of Endothelial Cells Induced by Oxidized Low Density Lipoprotein through Downregulating Expression of LOX-1

1
Department of Cardiology, Jiangsu Jiangyin People’s Hospital, 163 Shoushan Road, Jiangyin, Jiangsu, 214400, China
2
Department of Cardiology, Zhongda Hospital of Southeast University, 87 Dingjiqiao Hunan Road, Nanjing, Jiangsu, 210009, China
*
Author to whom correspondence should be addressed.
Received: 28 October 2011 / Revised: 27 December 2011 / Accepted: 27 December 2011 / Published: 1 February 2012
View Full-Text   |   Download PDF [411 KB, uploaded 19 June 2014]   |  

Abstract

Oxidized low density lipoprotein (ox-LDL) and its receptor, lectin-Like ox-LDL receptor-1 (LOX-1), play important roles in the development of endothelial injuries. Olmesartan can protect endothelial cells from the impairment caused by various pathological stimulations. In the present study we investigated whether olmesartan decreased the impairment of endothelial cells induced by ox-LDL by exerting its effects on LOX-1 both in vitro and in vivo. Incubation of cultured endothelial cells of neonatal rats with ox-LDL for 24 h or infusion of ox-LDL in mice for 3 weeks led to the remarkable impairment of endothelial cells, including increased lactate dehydrogenase synthesis, phosphorylation of p38 mitogen-activated protein kinases (p38 MAPK) and expression of apoptotic genes such as B-cell leukemia/lymphoma 2 (Bcl-2)-associated X protein (Bax) and caspase-3. Simultaneously, the cell vitality and expression of Bcl-2 gene were greatly reduced. All these effects, however, were significantly suppressed by the treatment with olmesartan. Furthermore, ox-LDL promoted up-regulation of LOX-1 expression either in cultured endothelial cells or in the aortas of mice, which was reversed with the administration of olmesartan. Our data indicated that olmesartan may attenuate the impairment of endothelial cell via down-regulation of the increased LOX-1 expression induced by ox-LDL.
Keywords: olmesartan; lox-1 receptor; endothelial cells; oxidized low density lipoprotein; apoptosis olmesartan; lox-1 receptor; endothelial cells; oxidized low density lipoprotein; apoptosis
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Zhang, H.; Ma, G.; Yao, Y.; Qian, H.; Li, W.; Chen, X.; Jiang, W.; Zheng, R. Olmesartan Attenuates the Impairment of Endothelial Cells Induced by Oxidized Low Density Lipoprotein through Downregulating Expression of LOX-1. Int. J. Mol. Sci. 2012, 13, 1512-1523.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top